Defining human mesenchymal stem cell efficacy in vivo

Allogeneic human mesenchymal stem cells (hMSCs) can suppress graft versus host disease (GvHD) and have profound anti-inflammatory and regenerative capacity in stroke, infarct, spinal cord injury, meniscus regeneration, tendinitis, acute renal failure, and heart disease in human and animal models of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bonfield, Tracey L, Nolan (Koloze), Mary T, Lennon, Donald P, Caplan, Arnold I
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2010
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2987779/ https://ncbi.nlm.nih.gov/pubmed/20974000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-9255-7-51
Tags:	Add Tag No Tags, Be the first to tag this record!

Defining human mesenchymal stem cell efficacy in vivo

Similar Items